Ocular Therapeutix Inc at JMP Securities Life Sciences Conference Transcript
Good afternoon, everybody. My name is Jon Wolleben, senior analyst with JMP Securities. And we're pleased to have Ocular Therapeutix joining us with CEO Antony Mattessich. Thanks for joining us, Antony.
Thanks for having me.
Questions & Answers
We've been talking a lot the past couple of weeks about a path forward with, primarily, OTX-TKI and a lot of questions. Would love to get an update on the program and then also the data that's upcoming, the 12-month follow-up, how we should think about that read-out.
Great. Well, I mean, a lot's been happening. It's been an incredibly busy time at Ocular Therapeutix, as you might imagine. But as we move forward, things get clearer and clearer. I think one of the main areas of clarity we have now is that we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
